| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,569 |
15,440 |
$2.39M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,915 |
6,419 |
$1.13M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,270 |
2,024 |
$446K |
| 80053 |
Comprehensive metabolic panel |
20,002 |
17,862 |
$334K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,452 |
1,309 |
$250K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,887 |
1,756 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,997 |
1,883 |
$163K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,617 |
2,435 |
$100K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,862 |
23,491 |
$84K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
173 |
167 |
$79K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,656 |
2,469 |
$74K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,836 |
3,246 |
$67K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,085 |
5,588 |
$67K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
468 |
445 |
$51K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,742 |
1,490 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
383 |
377 |
$40K |
| 71046 |
Radiologic examination, chest; 2 views |
870 |
840 |
$38K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
125 |
118 |
$33K |
| 83605 |
|
740 |
600 |
$27K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
251 |
163 |
$23K |
| 0012A |
|
292 |
276 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,479 |
1,391 |
$21K |
| 86140 |
|
1,489 |
1,378 |
$18K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
434 |
373 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
3,717 |
3,287 |
$14K |
| 0011A |
|
288 |
269 |
$13K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
531 |
517 |
$13K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
14 |
14 |
$11K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,459 |
1,008 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
640 |
563 |
$9K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,523 |
2,159 |
$9K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
13 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
94 |
82 |
$8K |
| 87081 |
|
349 |
329 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
463 |
431 |
$8K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
218 |
115 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
594 |
537 |
$7K |
| 84484 |
|
495 |
380 |
$7K |
| 86780 |
|
355 |
338 |
$6K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
12 |
$6K |
| 59025 |
Fetal non-stress test |
45 |
37 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
123 |
104 |
$6K |
| 87522 |
Neg quan hep c or qual rna |
55 |
51 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
84 |
77 |
$4K |
| 87340 |
|
354 |
336 |
$4K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
226 |
209 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,793 |
3,324 |
$4K |
| 86703 |
|
220 |
206 |
$4K |
| 73610 |
|
46 |
46 |
$4K |
| 86850 |
|
308 |
296 |
$4K |
| 86803 |
|
304 |
294 |
$4K |
| 83690 |
|
1,206 |
1,103 |
$4K |
| 87625 |
|
52 |
40 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
154 |
144 |
$3K |
| 81001 |
|
1,163 |
1,074 |
$3K |
| 73630 |
|
40 |
40 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
2,891 |
1,353 |
$2K |
| 80320 |
|
20 |
16 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
114 |
105 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
26 |
26 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
58 |
52 |
$2K |
| 86901 |
|
342 |
328 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
13 |
13 |
$2K |
| 86900 |
|
326 |
311 |
$2K |
| 87400 |
|
86 |
43 |
$2K |
| 80050 |
General health panel |
116 |
115 |
$2K |
| 83516 |
|
39 |
26 |
$1K |
| 82728 |
|
51 |
49 |
$1K |
| 85610 |
|
200 |
191 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
768 |
701 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
26 |
25 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
74 |
71 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
315 |
297 |
$1K |
| 81003 |
|
506 |
484 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
160 |
154 |
$1K |
| 80061 |
Lipid panel |
136 |
130 |
$1K |
| 86762 |
|
90 |
86 |
$1K |
| 97597 |
|
40 |
12 |
$1K |
| 73562 |
|
13 |
13 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
414 |
340 |
$870.49 |
| 82248 |
|
437 |
404 |
$863.69 |
| 87077 |
|
92 |
87 |
$840.16 |
| 84703 |
|
145 |
139 |
$765.22 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
33 |
32 |
$754.19 |
| 81025 |
|
123 |
114 |
$708.44 |
| 86359 |
|
13 |
12 |
$644.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
288 |
266 |
$565.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
333 |
322 |
$510.33 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,009 |
913 |
$497.40 |
| 94726 |
|
13 |
13 |
$389.06 |
| 87640 |
|
13 |
13 |
$387.90 |
| 86361 |
|
13 |
12 |
$329.64 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28 |
25 |
$299.11 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
109 |
102 |
$287.83 |
| 94729 |
|
13 |
13 |
$226.19 |
| 83540 |
|
12 |
12 |
$162.93 |
| 87641 |
|
13 |
13 |
$142.93 |
| 82565 |
|
29 |
26 |
$118.86 |
| 82105 |
|
13 |
13 |
$112.36 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
29 |
26 |
$96.63 |
| 82570 |
|
16 |
12 |
$88.92 |
| 85027 |
|
17 |
12 |
$63.57 |
| 84450 |
|
14 |
13 |
$58.31 |
| 84460 |
|
13 |
12 |
$54.32 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
13 |
13 |
$36.96 |
| 85652 |
|
16 |
14 |
$26.93 |
| A9270 |
Non-covered item or service |
39 |
13 |
$6.28 |
| 0753T |
|
215 |
161 |
$0.00 |
| J3490 |
Unclassified drugs |
11,771 |
5,848 |
$0.00 |
| 82077 |
|
15 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15 |
14 |
$0.00 |